The AHA July 16 urged the Center for Medicare and Medicaid Innovation not to implement its newly proposed Increasing Organ Transplant Access Model as currently constructed, expressing concerns about many of its design features. The proposed mandatory payment model would test whether performance-based incentive payments paid to or owed by participating kidney transplant hospitals would increase access to kidney transplants while preserving or enhancing the quality of care and reducing Medicare expenditures. AHA said that IOTA features could exacerbate inequities and negatively impact quality of care. Specifically, AHA said the IOTA model would add unnecessary disruption and uncertainty to the transplant ecosystem, potentially incentivize sub-par matches given the heavy emphasis on volume and would be discordant with other regulatory requirements. 

Headline
The AHA Sept. 23 submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act). The…
Headline
In part two of this special three-part Advancing Health podcast series, hear how leaders are creating new pathways into the workforce, investing in training,…
Headline
The Centers for Medicare & Medicaid Services has released preliminary calendar year 2027 Medicare clinical laboratory fee schedule payment rates. The rates…
Headline
Corey Casper, M.D., senior vice president and chief research officer at Banner Health, and professor of clinical translational science at the University of…
Headline
In episode one of Frontiers, a special three-part podcast series from the AHA that examines maternal health in rural America, learn how rural hospital leaders…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…